ERLOTINIB MAINTENANCE THERAPY FOR NON-SMALL CELL LUNG CANCER PRESERVES QUALITY OF LIFE

被引：1
|
作者：
Juhasz, E. [1 ]
Kim, J. H. [2 ]
Stelmakh, L. [3 ]
Cicenas, S. [4 ]
Klingelschmitt, G. [5 ]
机构：
[1] Orszagos Koranyi TBC, Budapest, Hungary
[2] St Vincents Hosp, Seoul, South Korea
[3] IP Pavlov State Med Univ, St Petersburg, Russia
[4] Vilnius Univ, Vilnius, Lithuania
[5] F Hoffmann La Roche Pharmaceut AG, Basel, Switzerland
来源：
VALUE IN HEALTH | 2010年 / 13卷 / 07期
关键词：
D O I：
10.1016/S1098-3015(11)72027-7
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A276 / A277
页数：2
相关论文
共 50 条
  • [41] Intercalation of Erlotinib and Pemetrexed in the Treatment of Non-Small Cell Lung Cancer
    Li, Tianhong
    Lara, Primo N., Jr.
    Mack, Philip C.
    Perez-Soler, Roman
    Gandara, David R.
    CURRENT DRUG TARGETS, 2010, 11 (01) : 85 - 94
  • [42] Use review of Erlotinib in advanced non-small cell lung cancer
    Alvarez-Payero, M.
    Ucha-Samartin, M.
    Martinez-Lopez-de-Castro, N.
    Campelo-Sanchez, E.
    Alvarez-Seoane, J.
    Vazquez-Lopez, C.
    Inaraja-Bobo, M. T.
    Perez Parente, D.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 438 - 438
  • [43] Review of erlotinib in the treatment of advanced non-small cell lung cancer
    Ganjoo, Kristen N.
    Wakelee, Heather
    BIOLOGICS-TARGETS & THERAPY, 2007, 1 (04): : 335 - 346
  • [44] Erlotinib: a new therapeutic approach for non-small cell lung cancer
    Bonomi, P
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (08) : 1395 - 1401
  • [45] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [46] MAINTENANCE ERLOTINIB VERSUS PEMETREXED FOR THE TREATMENT OF NON-SMALL CELL LUNG CANCER: INDIRECT COMPARISON APPLYING REAL-LIFE OUTCOMES
    Casciano, R.
    Bischoff, H.
    Nuijten, M.
    Malangone, E.
    Ray, J.
    VALUE IN HEALTH, 2010, 13 (07) : A254 - A254
  • [47] Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
    M. Faehling
    J. Achenbach
    P. Staib
    U. Steffen
    H. W. Tessen
    V. E. Gaillard
    W. Brugger
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1375 - 1383
  • [48] Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Faehling, M.
    Achenbach, J.
    Staib, P.
    Steffen, U.
    Tessen, H. W.
    Brugger, W.
    ANNALS OF ONCOLOGY, 2016, 27
  • [49] Erlotinib in routine clinical practice for first-line maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC)
    Faehling, M.
    Achenbach, J.
    Staib, P.
    Steffen, U.
    Tessen, H. W.
    Gaillard, V. E.
    Brugger, W.
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (07) : 1375 - 1383
  • [50] Erlotinib therapy in advanced non small-cell lung cancer
    Gazdulska, Joanna
    Bryl, Maciej
    Ramlau, Rodryg
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : G42 - G45
12345